Literature DB >> 16614590

Association of Chlamydia trachomatis Serovar Ia infection with black race in a sexually transmitted diseases clinic patient population in Birmingham, Alabama.

William M Geisler1, Robert J Suchland, Walter E Stamm.   

Abstract

BACKGROUND: Black race is a risk marker for Chlamydia trachomatis infection. Because chlamydial serovar and race could both influence the transmission dynamics of chlamydia, studies characterizing serovars in a predominantly black population are of interest, yet remain sparse. STUDY DESIGN AND GOALS: C. trachomatis isolates collected consecutively from 109 female and 98 male patients presenting to a sexually transmitted disease clinic in Birmingham, Alabama, were serotyped. Our goal was to evaluate serovar distribution and associated demographic characteristics in a predominantly black population.
RESULTS: The median age was 23 years and 91% were black. Serovars E (29%), D (19%), F (19%), Ia (16%), and J (9%) were the most prevalent. Blacks were less often infected with serovar E (30% vs. 41%) and J (9% vs. 24%), but more often infected with serovar Ia (17% vs. 0%) compared with individuals of other racial groups (P = 0.07). The overall serovar distribution did not significantly differ by gender or age; however, serovar Ia infections were associated with older age (21% in age >or=23 years vs. 10% in those age <23 years; P = 0.03).
CONCLUSIONS: Although the overall C. trachomatis serovar distribution in this predominantly black population in Birmingham was similar to that reported elsewhere, serovar Ia was only found in blacks, in whom it was commonly isolated. Finding differences in serovar distribution by race, particularly serovar Ia, may be of epidemiologic significance and deserves verification in similar cohorts.

Entities:  

Mesh:

Year:  2006        PMID: 16614590     DOI: 10.1097/01.olq.0000216027.71144.74

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  9 in total

1.  Gender and age disparities in the prevalence of Chlamydia infection among sexually active adults in the United States.

Authors:  Hind A Beydoun; Jessica Dail; Hala Tamim; Bethrand Ugwu; May A Beydoun
Journal:  J Womens Health (Larchmt)       Date:  2010-10-15       Impact factor: 2.681

2.  Evaluation of a novel PCR-based assay for detection and identification of Chlamydia trachomatis serovars in cervical specimens.

Authors:  Koen Quint; Carolina Porras; Mahboobeh Safaeian; Paula González; Allan Hildesheim; Wim Quint; Leen-Jan van Doorn; Sandra Silva; Willem Melchers; Mark Schiffman; Ana Cecilia Rodríguez; Sholom Wacholder; Enrique Freer; Bernal Cortes; Rolando Herrero
Journal:  J Clin Microbiol       Date:  2007-10-24       Impact factor: 5.948

3.  Absence of lymphogranuloma venereum strains among rectal Chlamydia trachomatis outer membrane protein A genotypes infecting women and men who have sex with men in Birmingham, Alabama.

Authors:  William M Geisler; Sandra G Morrison; Laura H Bachmann
Journal:  Sex Transm Dis       Date:  2008-10       Impact factor: 2.830

4.  Chlamydia trachomatis OmpA genotyping as a tool for studying the natural history of genital chlamydial infection.

Authors:  W M Geisler; C M Black; C I Bandea; S G Morrison
Journal:  Sex Transm Infect       Date:  2008-08-15       Impact factor: 3.519

5.  A novel whole-bacterial enzyme linked-immunosorbant assay to quantify Chlamydia trachomatis specific antibodies reveals distinct differences between systemic and genital compartments.

Authors:  Hannah L Albritton; Pamela A Kozlowski; Rebecca A Lillis; Chris L McGowin; Julia D Siren; Stephanie N Taylor; Joyce A Ibana; Lyndsey R Buckner; Li Shen; Alison J Quayle
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

6.  Detailed molecular epidemiology of Chlamydia trachomatis in the population of Southampton attending the genitourinary medicine clinic in 2012-13 reveals the presence of long established genotypes and transitory sexual networks.

Authors:  Clare Labiran; David Rowen; Ian Nicholas Clarke; Peter Marsh
Journal:  PLoS One       Date:  2017-09-25       Impact factor: 3.240

7.  Frequency and genotypes of Chlamydia trachomatis in patients attending the obstetrics and gynecology clinics in Jalisco, Mexico and correlation with sociodemographic, behavioral, and biological factors.

Authors:  Néstor Casillas-Vega; Rayo Morfín-Otero; Santos García; Jorge Llaca-Díaz; Eduardo Rodríguez-Noriega; Adrián Camacho-Ortiz; Ma de la Merced Ayala-Castellanos; Héctor J Maldonado-Garza; Jesús Ancer-Rodríguez; Guadalupe Gallegos-Ávila; Alberto Niderhauser-García; Elvira Garza-González
Journal:  BMC Womens Health       Date:  2017-09-15       Impact factor: 2.809

8.  A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C/C-related complex serovars.

Authors:  Anja Weinreich Olsen; Ida Rosenkrands; Martin J Holland; Peter Andersen; Frank Follmann
Journal:  NPJ Vaccines       Date:  2021-04-19       Impact factor: 9.399

9.  Urogenital Chlamydia trachomatis infections among ethnic groups in Paramaribo, Suriname; determinants and ethnic sexual mixing patterns.

Authors:  Jannie J van der Helm; Reinier J M Bom; Antoon W Grünberg; Sylvia M Bruisten; Maarten F Schim van der Loeff; Leslie O A Sabajo; Henry J C de Vries
Journal:  PLoS One       Date:  2013-07-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.